Tafazoli, A.; Wołczyński, S.; Wawrusiewicz-Kurylonek, N.; Esmaeili, S.-A.; Miltyk, W.
Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey. J. Clin. Med. 2021, 10, 170.
https://doi.org/10.3390/jcm10020170
AMA Style
Tafazoli A, Wołczyński S, Wawrusiewicz-Kurylonek N, Esmaeili S-A, Miltyk W.
Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey. Journal of Clinical Medicine. 2021; 10(2):170.
https://doi.org/10.3390/jcm10020170
Chicago/Turabian Style
Tafazoli, Alireza, Sławomir Wołczyński, Natalia Wawrusiewicz-Kurylonek, Seyed-Alireza Esmaeili, and Wojciech Miltyk.
2021. "Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey" Journal of Clinical Medicine 10, no. 2: 170.
https://doi.org/10.3390/jcm10020170
APA Style
Tafazoli, A., Wołczyński, S., Wawrusiewicz-Kurylonek, N., Esmaeili, S.-A., & Miltyk, W.
(2021). Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey. Journal of Clinical Medicine, 10(2), 170.
https://doi.org/10.3390/jcm10020170